Geoffrey A Donnan Selected Research

Carotid Endarterectomy

10/2019	Ischaemic stroke.
1/2017	Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.
1/2008	The role of neuroimaging in acute stroke.
1/2004	High intensity transient signals in patients with carotid stenosis may persist after carotid endarterectomy.
8/2002	Possible determinants of early microembolism after carotid endarterectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geoffrey A Donnan Research Topics

Disease

158	Stroke (Strokes) 03/2024 - 01/2002
108	Ischemic Stroke 03/2024 - 01/2002
27	Infarction (Infarctions) 01/2022 - 01/2002
13	Hemorrhage 01/2023 - 01/2010
9	Cerebral Hemorrhage 03/2022 - 06/2006
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 09/2008
8	Hypertension (High Blood Pressure) 01/2022 - 02/2002
8	Cerebral Infarction 01/2020 - 01/2002
7	Atrial Fibrillation 10/2019 - 04/2002
6	Hematoma 03/2022 - 11/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 09/2002
5	Edema (Dropsy) 01/2022 - 08/2013
5	Brain Edema (Cerebral Edema) 01/2022 - 08/2013
5	Ischemia 08/2018 - 05/2004
4	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2022 - 01/2014
4	Dementia (Dementias) 01/2021 - 10/2004
4	Brain Ischemia (Cerebral Ischemia) 05/2012 - 01/2008
3	Thrombosis (Thrombus) 01/2023 - 01/2018
3	Carotid Stenosis (Carotid Artery Stenosis) 10/2019 - 01/2004
3	Body Weight (Weight, Body) 01/2018 - 03/2015
3	Transient Ischemic Attack 01/2017 - 05/2012
3	Cognitive Dysfunction 01/2017 - 10/2008
3	Hypoxia (Hypoxemia) 03/2011 - 07/2006
2	Hyperglycemia 12/2023 - 01/2019
2	Hemorrhagic Stroke 01/2023 - 01/2021
2	Chronic Renal Insufficiency 11/2022 - 01/2021
2	Inflammation (Inflammations) 01/2016 - 01/2006
2	Embolism (Embolus) 05/2014 - 04/2012
2	Hypothermia 08/2013 - 12/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2011 - 09/2003
1	Vomiting 12/2023
1	Hypoglycemia (Reactive Hypoglycemia) 12/2023
1	Nausea 12/2023
1	COVID-19 05/2022
1	Frailty 01/2021
1	Wounds and Injuries (Trauma) 12/2020
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2019

Drug/Important Bio-Agent (IBA)

65	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 01/2005
19	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 05/2004
18	Tenecteplase FDA Link 01/2023 - 01/2014
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2004
9	Neuroprotective AgentsIBA 08/2018 - 05/2004
6	Cytidine Triphosphate (CTP)IBA 10/2018 - 01/2008
6	Warfarin (Coumadin)FDA LinkGeneric 05/2014 - 05/2004
5	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 08/2013
5	fluoromisonidazoleIBA 03/2011 - 02/2004
4	Tranexamic Acid (AMCA)FDA Link 03/2022 - 06/2014
4	CholesterolIBA 10/2019 - 02/2002
4	Clopidogrel (Plavix)FDA Link 05/2014 - 11/2004
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022 - 06/2011
3	Indicators and Reagents (Reagents)IBA 01/2020 - 08/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2014
3	disufenton sodium (NXY 059)IBA 08/2018 - 08/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2008
3	Angiotensin Receptor AntagonistsIBA 09/2009 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2015
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2016
2	LipidsIBA 01/2018 - 01/2012
2	ORALIT (ORS)IBA 07/2017 - 06/2005
2	Glyburide (Glibenclamide)FDA LinkGeneric 08/2014 - 01/2014
2	Amyloid (Amyloid Fibrils)IBA 05/2012 - 12/2010
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 05/2012 - 12/2010
2	Desmodus rotundus salivary plasminogen activator alpha 1IBA 01/2010 - 03/2009
2	Telmisartan (Micardis)FDA Link 10/2008 - 09/2008
2	Dipyridamole (Persantine)FDA LinkGeneric 10/2008 - 09/2008
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2008 - 01/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2008 - 04/2002
2	Perindopril FDA LinkGeneric 06/2003 - 02/2003
2	Heparin (Liquaemin)FDA LinkGeneric 04/2003 - 01/2003
1	Insulin (Novolin)FDA Link 12/2023
1	Exenatide (Byetta)FDA Link 12/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023
1	FibrinIBA 05/2022
1	GadoliniumIBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Edetic Acid (EDTA)FDA Link 01/2020
1	Complement C9 (Complement Component 9)IBA 01/2020
1	VitronectinIBA 01/2020
1	ClusterinIBA 01/2020
1	Dabigatran FDA Link 01/2019

Therapy/Procedure

74	Therapeutics 01/2024 - 01/2002
33	Thrombectomy 12/2023 - 03/2015
13	Thrombolytic Therapy 06/2016 - 11/2002
10	Secondary Prevention 01/2023 - 02/2003
6	Stents 01/2019 - 03/2015
5	Carotid Endarterectomy 10/2019 - 08/2002
5	Treatment Delay 05/2017 - 04/2014
4	Contraindications 01/2020 - 10/2017
4	Time-to-Treatment 06/2019 - 05/2010
3	Aftercare (After-Treatment) 01/2019 - 07/2013
3	Institutionalization (Institutionalized Persons) 10/2004 - 12/2002
2	Length of Stay 01/2021 - 04/2003
2	Patient Readmission 12/2020 - 07/2015
2	Early Ambulation 11/2020 - 01/2011
2	Catheters 01/2020 - 01/2018
1	Subcutaneous Injections 12/2023
1	Critical Care (Surgical Intensive Care) 09/2021
1	Subacute Care 12/2020
1	Punctures 01/2019